Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation

In patients with chronic lymphocytic leukemia (CLL), persistence of disease after allogeneic stem cell transplantation (alloSCT) can result in poor outcomes. In an effort to improve these outcomes, patients with persistent CLL who were 90–100 days post alloSCT with no evidence of graft-versus-host-d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Khouri, Maria R., Jabbour, Elias J., Gulbis, Alison M., Turturro, Francesco, Ledesma, Celina, Korbling, Martin, Samuels, Barry I., Ahmed, Sairah, Alousi, Amin M., Ciurea, Stefan O., Marin, David, Patel, Krina K., Popat, Uday R., Bueso-Ramos, Carlos E., Bassett, Roland L., Khouri, Issa F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141702/
https://ncbi.nlm.nih.gov/pubmed/28495642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.04.027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados